The role of Wnt signaling in mesenchymal stromal cell-driven angiogenesis

Copyright © 2023 Elsevier Ltd. All rights reserved..

Development, growth, and remodeling of blood vessels occur through an intricate process involving cell differentiation, proliferation, and rearrangement by cell migration under the direction of various signaling pathways. Recent reports highlight that resident and exogenous mesenchymal stromal cells (MSCs) have the potential to regulate the neovascularization process through paracrine secretion of proangiogenic factors. Recent research has established that the vasculogenic potential of MSCs is regulated by several signaling pathways, including the Wnt signaling pathway, and their interplay. These findings emphasize the complex nature of the vasculogenic process and underscore the importance of understanding the underlying molecular mechanisms for the development of effective cell-based therapies in regenerative medicine. This review provides an updated briefing on the canonical and non-canonical Wnt signaling pathways and summarizes the recent reports of both in vitro and in vivo studies with the involvement of MSCs of various sources in the vasculogenic process mediated by Wnt signaling pathways. Here we outline the current understanding of the plausible role of the Wnt signaling pathway, specifically in MSC-regulated angiogenesis.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:85

Enthalten in:

Tissue & cell - 85(2023) vom: 15. Dez., Seite 102240

Sprache:

Englisch

Beteiligte Personen:

Mankuzhy, Pratheesh [VerfasserIn]
Dharmarajan, Arun [VerfasserIn]
Perumalsamy, Lakshmi R [VerfasserIn]
Sharun, Khan [VerfasserIn]
Samji, Priyanka [VerfasserIn]
Dilley, Rodney J [VerfasserIn]

Links:

Volltext

Themen:

Angiogenesis
Journal Article
Mesenchymal stromal cells
Neovascularization
Preclinical studies
Review
Vasculogenesis
Wnt signaling

Anmerkungen:

Date Completed 13.11.2023

Date Revised 29.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.tice.2023.102240

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363715010